These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 29614816)

  • 1. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
    Stampone E; Caldarelli I; Zullo A; Bencivenga D; Mancini FP; Della Ragione F; Borriello A
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p57(Kip2) and cancer: time for a critical appraisal.
    Borriello A; Caldarelli I; Bencivenga D; Criscuolo M; Cucciolla V; Tramontano A; Oliva A; Perrotta S; Della Ragione F
    Mol Cancer Res; 2011 Oct; 9(10):1269-84. PubMed ID: 21816904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
    Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
    Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Beckwith-Wiedemann-Associated
    Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p57KIP2: "Kip"ing the cell under control.
    Pateras IS; Apostolopoulou K; Niforou K; Kotsinas A; Gorgoulis VG
    Mol Cancer Res; 2009 Dec; 7(12):1902-19. PubMed ID: 19934273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
    Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
    Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Versatility of the CDK Inhibitor p57
    Creff J; Besson A
    Front Cell Dev Biol; 2020; 8():584590. PubMed ID: 33117811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distant cis-elements regulate imprinted expression of the mouse p57( Kip2) (Cdkn1c) gene: implications for the human disorder, Beckwith--Wiedemann syndrome.
    John RM; Ainscough JF; Barton SC; Surani MA
    Hum Mol Genet; 2001 Jul; 10(15):1601-9. PubMed ID: 11468278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation of
    Rossi MN; Andresini O; Matteini F; Maione R
    Front Biosci (Landmark Ed); 2018 Jan; 23(1):83-108. PubMed ID: 28930539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
    Tury A; Mairet-Coello G; DiCicco-Bloom E
    Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
    Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
    J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.
    Tury A; Mairet-Coello G; DiCicco-Bloom E
    Dev Neurobiol; 2012 Jun; 72(6):821-42. PubMed ID: 22076965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix.
    Purba TS; Brunken L; Peake M; Shahmalak A; Chaves A; Poblet E; Ceballos L; Gandarillas A; Paus R
    Eur J Cell Biol; 2017 Sep; 96(6):632-641. PubMed ID: 28413121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-talk between DNA methylation and H3 lysine 9 dimethylation at the KvDMR1 region controls the induction of Cdkn1c in muscle cells.
    Andresini O; Ciotti A; Rossi MN; Battistelli C; Carbone M; Maione R
    Epigenetics; 2016 Nov; 11(11):791-803. PubMed ID: 27611768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
    Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
    Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hallmarks of CDKN1C (p57, KIP2) in cancer.
    Kavanagh E; Joseph B
    Biochim Biophys Acta; 2011 Aug; 1816(1):50-6. PubMed ID: 21447370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle regulator Cdkn1c (p57/KIP2) shows distinct expression in epidermal differentiation.
    Hildebrand J; Spörl F; Korge S; Gallinat S; Wenck H; Deppert W; Knott A; Blatt T
    Eur J Dermatol; 2012; 22(5):694-6. PubMed ID: 23008285
    [No Abstract]   [Full Text] [Related]  

  • 18. The developmental expression of the CDK inhibitor p57(kip2) (Cdkn1c) in the early mouse placenta.
    Saunders AC; McGonnigal B; Uzun A; Padbury J
    Mol Reprod Dev; 2016 May; 83(5):405-12. PubMed ID: 26988311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
    Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
    Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mechanisms downregulate CDKN1C in human bladder cancer.
    Hoffmann MJ; Florl AR; Seifert HH; Schulz WA
    Int J Cancer; 2005 Apr; 114(3):406-13. PubMed ID: 15551363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.